Tropical diseases

ERVEBO® [Ebola Zaire Vaccine] Awarded Prequalification Status by the World Health Organization (WHO)

MERCK (NYSE: MRK), known as MSD (www.MSD.com) outside the United States and Canada, today announced that ERVEBO [Ebola Zaire Vaccine (rVSVΔ-ZEBOV-GP live)] has been awarded prequalification status by the World Health Organization (WHO).

Novartis announces new strategy to provide innovative medicines to more patients in sub-Saharan Africa

Novartis announced today a new strategy to broaden patient reach and availability of its portfolio of medicines in sub-Saharan Africa (SSA), which is home to the largest underserved patient population in the world.